| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 06/08/2006 | WO2003086292A3 Use of na,k-atpase a-and b-subunits in bladder cancer detection and drug screening |
| 06/08/2006 | WO2003076571A3 Cancer-linked gene as target for chemotherapy |
| 06/08/2006 | US20060123498 Paks as modifiers of the chk pathway and methods of use |
| 06/08/2006 | US20060123496 Animal models |
| 06/08/2006 | US20060123495 Knockout mice and their use |
| 06/08/2006 | US20060123492 Methods of identifying modulators of NMUR2-mediated activity |
| 06/08/2006 | US20060123487 Methods of screening agents for activity using teleosts |
| 06/08/2006 | US20060122816 Computer systems and methods for subdividing a complex disease into component diseases |
| 06/08/2006 | US20060122789 Symmetry relationships between pairs of connectrons |
| 06/08/2006 | US20060122788 Method of identifying changes in biopolymers |
| 06/08/2006 | US20060122785 Constellation mapping and uses thereof |
| 06/08/2006 | US20060122781 Method and arrangement for detecting and measuring the phase of periodical biosignals |
| 06/08/2006 | US20060122498 Optical projection tomography |
| 06/08/2006 | US20060122372 Polymorphisms in the human genes for oct1 and their use in diagnostic and therapeutic applications |
| 06/08/2006 | US20060122269 Compounds that abrogate DNA damage induced cell cycle G2 checkpoint and/or augment anti-cancer activity of DNA-damaging treatments |
| 06/08/2006 | US20060122111 Regeneration and neogenesis of retinal visual cell otx2 gene |
| 06/08/2006 | US20060122110 Nogo, caspr, f3 nb-3 useful in the treatment of injury and disease to the central nervous system |
| 06/08/2006 | US20060122107 Method of modulating cellular activity and molecules for use therein |
| 06/08/2006 | US20060122106 Prevention and/or treatment of inflammatory bowel disease using pyy or agonists thereof |
| 06/08/2006 | US20060121800 Connecting lead for a sensor |
| 06/08/2006 | US20060121628 With fine protein nanoparticles that are arranged at a high density in a highly accurate and regular manner on a negativly charged substrate; the particles are modified apoferritin and each adjacent two particles has their COO- groups neutralized by a divalent cation |
| 06/08/2006 | US20060121627 Diluent, methods of manufacture and use |
| 06/08/2006 | US20060121626 Diagnostic assay device |
| 06/08/2006 | US20060121625 all of the electrical apparatus components are formed on the basis of polymer electronics, so that the analyte can be determined straightforwardly, conveniently and inexpensively |
| 06/08/2006 | US20060121623 Luminescent indicator dye and optical sensor |
| 06/08/2006 | US20060121622 Method for determination of organic hydroperoxides |
| 06/08/2006 | US20060121621 Nitrate/nitrite assay reagents, kit, and method of use |
| 06/08/2006 | US20060121620 Nitrate/nitrite assay reagents, kit, and method of use |
| 06/08/2006 | US20060121619 Protein biomarkers and therapeutic targets in an animal model for amyotrophic lateral sclerosis |
| 06/08/2006 | US20060121618 Method and system for identifying polypeptides |
| 06/08/2006 | US20060121617 contacting a thrombin substrate with coagulating blood or plasma, allowing cleavage of the thrombin substrate, measuring turnover kinetics of the thrombin substrate as a function of time, wherein the turnover kinetics comprise a saturation phase, saturation phase comprises a linear region, |
| 06/08/2006 | US20060121615 Exposing fresh surface of a quantity of rock sample potentially comprising zero-valent transition metal, exposing the rock sample to hydrogen gas and a hydrocarbon material, detecting the presence of methane catalytically-generated by zero-valent transition metal potentially present in rock sample |
| 06/08/2006 | US20060121614 Multichannel fluorosensor |
| 06/08/2006 | US20060121613 Process for detecting leaks in sealed packages |
| 06/08/2006 | US20060121610 Transferring particles through cell barriers; insert cell into electrically conductive fluid, monitor electrical current, adjust voltage to maintain preferential diffusion |
| 06/08/2006 | US20060121599 Method for producing a sample carrier for maldi-mass spectrometry |
| 06/08/2006 | US20060121598 System for detecting at least one chemical substance |
| 06/08/2006 | US20060121596 Core sampling device intended to assemble tissue arrays |
| 06/08/2006 | US20060121545 Rapamycin conjugates and antibodies |
| 06/08/2006 | US20060121544 Molecular modification assays |
| 06/08/2006 | US20060121543 Chemical arrays and methods of using the same |
| 06/08/2006 | US20060121542 Insulin-like growth factor system and cancer |
| 06/08/2006 | US20060121541 Use of endosialin binding proteins to isolate endosialin positive cells |
| 06/08/2006 | US20060121540 Use of protein MASP as a marker for colorectal cancer |
| 06/08/2006 | US20060121539 Eph receptor tumor biomarkers |
| 06/08/2006 | US20060121538 Peptides having affinity for the gp120 viral protein and use thereof |
| 06/08/2006 | US20060121537 Cellular immunity test with peptides fixed on a solid support |
| 06/08/2006 | US20060121536 Novel uses of antibodies against AChE and peptides thereof |
| 06/08/2006 | US20060121535 Polyacrylamide-based methods of fabricating surface-bound peptide and protein arrays; detecting surface-immobilized biomolecules |
| 06/08/2006 | US20060121534 Methods for culturing mammalian taste cells |
| 06/08/2006 | US20060121533 Analysis of proteins from biological fluids using mass spectrometric immunoassay |
| 06/08/2006 | US20060121532 Glycated insulin as a biomarker for diagnosis and monitoring of diabetes |
| 06/08/2006 | US20060121531 Piezoelectric bio-chip for detecting pathogen of mad cow disease and thereon preparation |
| 06/08/2006 | US20060121529 CpG receptor (CpG-R) and methods relating thereto |
| 06/08/2006 | US20060121526 Method of determining a chemotherapeutic regimen based on ERCC1 and TS expression |
| 06/08/2006 | US20060121519 Ligand and coordinating moiety for isolating preferential macromolecules in solution |
| 06/08/2006 | US20060121518 Polypeptide encoded by nucleic acid of given sequence; Glycerol-3-phosphate; modulators of cellular metabolism, energy homeostasis, signal transduction and cell proliferation |
| 06/08/2006 | US20060121514 Prostacyclin-stimulating Factor-2 |
| 06/08/2006 | US20060121512 Biological pathways in progenitor cells |
| 06/08/2006 | US20060121511 Biomarkers and methods for determining sensitivity to microtubule-stabilizing agents |
| 06/08/2006 | US20060121508 Alternatively spliced isoforms of purinergic receptor P2X, ligand-gated ion channel, subunits 3 and 4 (P2RX3, P2RX4) |
| 06/08/2006 | US20060121506 light emitting compositions that comprise a polymeric matrix having dissolved therein a photoactive compound; kits for use in an assay |
| 06/08/2006 | US20060121503 Chemically reactive carbocyanine dyes that are intramolecularly connected or crosslinked between the 1-position and 3'-position by a polyamino acid linker; reduction of the ground state aggregation caused by steric hindrance of the crosslinking results in more fluorescent on proteins and nucleic acids |
| 06/08/2006 | US20060121502 Microfluidics apparatus for cantilevers and methods of use therefor |
| 06/08/2006 | US20060121498 Enzymes involved in apoptosis |
| 06/08/2006 | US20060121496 screening for an inhibitor of damage associated with myocardial ischemia comprising treating myocytes having gene expresssion for integrin-linked kinase (ILK) and/or Akt/protein kinase B (PKB) and measuring expression, activity or stability of ILK and/or Akt/PKB, in the myocytes |
| 06/08/2006 | US20060121494 Diagnosis and treatment of tumors in infants; obtain tissue sample, monitor preferential gene expression, amplified gene expression indicates tumor; determining whether a subject with neuroblastoma has a stage I, stage II, stage III, or stage IV; detecting Id2 protein in intact cells |
| 06/08/2006 | US20060121489 High throughput screening of aptamer libraries for specific binding to proteins on viruses and other pathogens |
| 06/08/2006 | US20060121485 Compounds and methods for detection of carcinomas and their precursor lesions |
| 06/08/2006 | US20060121483 Methods for detecting teneurin signalling and related screening methods |
| 06/08/2006 | US20060121481 Method for screening molecular interactions |
| 06/08/2006 | US20060121478 Actn3 genotype screen for athletic performance |
| 06/08/2006 | US20060121476 Cancer associated antigens, sga-56m and sga-56mv, and uses thereof |
| 06/08/2006 | US20060121474 Bio-chip prepared by gelation on a chip substrate |
| 06/08/2006 | US20060121471 Gene families associated with stomach cancer |
| 06/08/2006 | US20060121469 Screening for anti-ovulatory compounds |
| 06/08/2006 | US20060121465 Sgk and nedd used as diagnostic and therapeutic targets |
| 06/08/2006 | US20060121462 Receptor and screening methods |
| 06/08/2006 | US20060121460 Toll-like receptor 11 |
| 06/08/2006 | US20060121459 Receptors and membrane-associated proteins |
| 06/08/2006 | US20060121457 Gfats as modifiers of the p53 pathway and methods of use |
| 06/08/2006 | US20060121454 diagnosis and treatment of carcinomas, especially breast cancers |
| 06/08/2006 | US20060121453 Pre-incubation assay methods |
| 06/08/2006 | US20060121449 Method for selection of compounds which inhibit clonal cell growth and use thereof |
| 06/08/2006 | US20060121448 Method for inducing complete hepatitis c virus (hcv) replication in vitro |
| 06/08/2006 | US20060121447 Purified subfragment codifying for neuroaminidase, recombinant neuroaminidase and its use in zooprophylaxis |
| 06/08/2006 | US20060121442 illuminating and producing an image; examining spatial structure and distribution of light energy |
| 06/08/2006 | US20060121163 Beverage management system |
| 06/08/2006 | US20060121128 Increasing cytosolic calcium levels in airway epithelial cell by contacting purinergic (P2X) receptors on cell with zinc chloride; cystic fibrosis, asthma, allergies, polycystic kidney disease and salt-sensitive hypertension syndromes, diabetes; drug screening; nasal spray |
| 06/08/2006 | US20060121041 Gpcs as modifiers of the irrtk p21 pathways and methods of use |
| 06/08/2006 | US20060121033 Using antibodies which bind specifically to DC-SIGN; Agents that bind to ICAM-3 are used to block inhibition of activation of macrophages by DC-SIGN-ICAM-3 interaction and cause inhibition of rheumatoid arthritis symptoms |
| 06/08/2006 | US20060121027 Method for detecting and isolating t lymphocytes that recognize a defined antigen |
| 06/08/2006 | US20060121025 VEGF-related protein |
| 06/08/2006 | US20060120992 Rapid dehydration of proteins |
| 06/08/2006 | US20060120963 Method of identifying therapeutic compounds for a treatment of hepatic disorders |
| 06/08/2006 | US20060120961 Glycan analysis using deuterated glucose |
| 06/08/2006 | US20060120926 Liquid storage container and cartridge |
| 06/08/2006 | US20060120919 Analyte accumulation device |
| 06/08/2006 | US20060120918 Sensitivity and is excellent in response gas; tecting a gas (gas molecules etc.), a biosensor detecting a biomaterial such as protein, or a pH sensor detecting pH in a solution |
| 06/08/2006 | US20060120835 Article handling system and method |